aparoscopic silastic ring Roux -En-Y gastric bypass versus duodenal switch as revisional procedures following sleeve gastrectomy: A Prospective, Randomized Controlled Non-Inferiority Trial

Waitemata DHB0 个研究点目标入组 52 人开始时间: 2022年4月12日最近更新: 2022年4月19日

适应症

试验速览

暂无简介。

•previous sleeve gastrectomy (at least 24 months prior) and
•Weight greater than 45kg above the ideal body weight for sex, and height.
•BMI >; 40 by itself or >35 if there is an associated obesity illness , such as diabetes or
•sleep apnoea
•Reasonable attempts at other weight loss techniques
•Age 18-65yrs
•Obesity related health problems
•No psychiatric or drug dependency problems
•A capacity to understand the risks and commitment associated with the surgery.
•Pregnancy not anticipated in the first two years following surgery

•Current smoker
•Current drug or alcohol abuse
•Malabsorptive or inflammatory bowel disease
•Unstable psychiatric disorder
•History of chronic pancreatitis or idiopathic acute pancreatitis.
•Severe cardiorespiratory disease or other conditions contraindicating anaesthesia
•Active malignancy
•Patients with severe reflux oesophagitis or Barrett’s oesophagus
•Patients grossly dilated or strictured gastric sleeves

发起方

Waitemata DHB